Galera Therapeutics, Inc. (GRTX): SCHEDULE 13D filed Apr 27, 2026

Form type

SCHEDULE 13D

Filing date

Apr 27, 2026

Accession number

0001123292-26-000583

Filer

Galera Therapeutics, Inc. (CIK 1563577)